Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Capital Expenditures (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of Capital Expenditures data on record, last reported at $11.1 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 41.87% year-over-year to $11.1 million; the TTM value through Dec 2025 reached $14.3 million, down 64.32%, while the annual FY2025 figure was $6.8 million, 83.39% down from the prior year.
  • Capital Expenditures reached $11.1 million in Q4 2025 per PAHC's latest filing, down from $13.8 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $23.2 million in Q3 2022 and bottomed at -$19.3 million in Q2 2021.
  • Average Capital Expenditures over 5 years is $7.5 million, with a median of $9.7 million recorded in 2024.
  • Peak YoY movement for Capital Expenditures: skyrocketed 211.13% in 2022, then crashed 240.01% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at $7.7 million in 2021, then rose by 27.69% to $9.8 million in 2022, then grew by 11.61% to $11.0 million in 2023, then fell by 28.62% to $7.8 million in 2024, then skyrocketed by 41.87% to $11.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $11.1 million in Q4 2025, $13.8 million in Q3 2025, and -$18.3 million in Q2 2025.